ArticleCancers2020

Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma.

Bettina Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.